propafenone has been researched along with Hypotension in 9 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective, randomized, double-blind study to compare the efficacy in terminating postoperative atrial fibrillation of the class Ic drug propafenone versus class Ia drug procainamide was conducted." | 9.09 | Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. ( Geelen, P; O'Hara, GE; Plante, S; Roy, D; Roy, N; Talajic, M; Turgeon, J, 1999) |
| "We present two cases of proarrhythmia after propafenone treatment." | 7.74 | [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. ( Jastrzebski, M, 2008) |
| "The safety and efficacy of intravenous Propafenone, in the treatment of atrial fibrillation (a." | 7.67 | [Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone]. ( Bianconi, L; Boccadamo, R; Broglia, R; Pappalardo, A; Pistolese, M, 1987) |
| "A prospective, randomized, double-blind study to compare the efficacy in terminating postoperative atrial fibrillation of the class Ic drug propafenone versus class Ia drug procainamide was conducted." | 5.09 | Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. ( Geelen, P; O'Hara, GE; Plante, S; Roy, D; Roy, N; Talajic, M; Turgeon, J, 1999) |
| "We present two cases of proarrhythmia after propafenone treatment." | 3.74 | [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. ( Jastrzebski, M, 2008) |
| "The safety and efficacy of intravenous Propafenone, in the treatment of atrial fibrillation (a." | 3.67 | [Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone]. ( Bianconi, L; Boccadamo, R; Broglia, R; Pappalardo, A; Pistolese, M, 1987) |
| "Guidelines recommend that initial trial of a "pill-in-the-pocket" (PIP) Class 1C antiarrhythmic drug (AAD) for cardioversion of atrial fibrillation (AF) be performed in a monitored setting because of the potential for adverse reactions." | 1.72 | Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation. ( Arkles, JS; Callans, DJ; Deo, R; Dixit, S; Epstein, AE; Frankel, DS; Guandalini, GS; Hyman, MC; Jarrah, AA; Lin, D; Marchlinski, FE; Markman, TM; Mustin, E; Nazarian, S; Riley, M; Santangeli, P; Schaller, RD; Supple, GE; Tian, Y, 2022) |
| "Propafenone is a sodium-channel blocker, class IC antiarrhythmic drug, frequently used to manage supraventricular dysrhythmias, especially atrial fibrillation." | 1.48 | Failure of Intracardiac Pacing After Fatal Propafenone Overdose: A Case Report. ( Brkljačić, DD; Bulj, N; Čabrilo, V; Kolačević, M; Manola, Š; Zeljković, I, 2018) |
| "Propafenone is a Vaughan Williams class 1c antiarrhythmic medication widely used for treatment of arrhythmias." | 1.46 | Revisiting propafenone toxicity. ( Alsaad, AA; Austin, CO; Kusumoto, F; Ortiz Gonzalez, Y, 2017) |
| "Two patients with recurrences of sustained VT in this group were later successfully treated with propafenone, 900 mg/day; overall, 8 of 9 patients with recurrences of sustained VT were successfully treated with 900 mg/day." | 1.27 | Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment. ( Ambrosioni, E; Bracchetti, D; Marchesini, B; Naccarella, F; Palmieri, M, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Markman, TM | 1 |
| Jarrah, AA | 1 |
| Tian, Y | 1 |
| Mustin, E | 1 |
| Guandalini, GS | 1 |
| Lin, D | 1 |
| Epstein, AE | 1 |
| Hyman, MC | 1 |
| Deo, R | 1 |
| Supple, GE | 1 |
| Arkles, JS | 1 |
| Dixit, S | 1 |
| Schaller, RD | 1 |
| Santangeli, P | 1 |
| Nazarian, S | 1 |
| Riley, M | 1 |
| Callans, DJ | 1 |
| Marchlinski, FE | 1 |
| Frankel, DS | 1 |
| Alsaad, AA | 1 |
| Ortiz Gonzalez, Y | 1 |
| Austin, CO | 1 |
| Kusumoto, F | 1 |
| Zeljković, I | 1 |
| Bulj, N | 1 |
| Kolačević, M | 1 |
| Čabrilo, V | 1 |
| Brkljačić, DD | 1 |
| Manola, Š | 1 |
| Tsiperfal, A | 1 |
| Scheibly, K | 1 |
| Matsuda, K | 1 |
| Jastrzebski, M | 1 |
| Unal, S | 1 |
| Bayrakci, B | 1 |
| Yasar, U | 1 |
| Karagoz, T | 1 |
| Naccarella, F | 1 |
| Bracchetti, D | 1 |
| Palmieri, M | 1 |
| Marchesini, B | 1 |
| Ambrosioni, E | 1 |
| Geelen, P | 1 |
| O'Hara, GE | 1 |
| Roy, N | 1 |
| Talajic, M | 1 |
| Roy, D | 1 |
| Plante, S | 1 |
| Turgeon, J | 1 |
| Bianconi, L | 1 |
| Boccadamo, R | 1 |
| Pappalardo, A | 1 |
| Broglia, R | 1 |
| Pistolese, M | 1 |
1 trial available for propafenone and Hypotension
| Article | Year |
|---|---|
Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary Artery Bypa | 1999 |
8 other studies available for propafenone and Hypotension
| Article | Year |
|---|---|
Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Female; Flecainide; Humans; H | 2022 |
Revisiting propafenone toxicity.
Topics: Aged; Anti-Arrhythmia Agents; Bradycardia; Humans; Hypotension; Male; Propafenone | 2017 |
Failure of Intracardiac Pacing After Fatal Propafenone Overdose: A Case Report.
Topics: Aged; Autopsy; Cardiac Catheters; Cardiac Pacing, Artificial; Consciousness Disorders; Drug Overdose | 2018 |
Can QRS Widening be a result of propafenone overdose?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Consciousness Disorders; Drug Ove | 2008 |
[Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bundle-Branch Blo | 2008 |
Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.
Topics: Adolescent; Anti-Arrhythmia Agents; Anticoagulants; Bradycardia; Cytochrome P-450 Enzyme System; Dig | 2007 |
Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Dizziness; Female; Humans | 1984 |
[Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone].
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Humans; Hypotension; In | 1987 |